111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.85%
Positive revenue growth while CX is negative. John Neff might see a notable competitive edge here.
-22.92%
Negative gross profit growth while CX is at 0.86%. Joel Greenblatt would examine cost competitiveness or demand decline.
144.78%
EBIT growth above 1.5x CX's 6.30%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
144.78%
Operating income growth above 1.5x CX's 6.30%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-39.05%
Negative net income growth while CX stands at 95.41%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-99.75%
Negative EPS growth while CX is at 484.62%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-99.75%
Negative diluted EPS growth while CX is at 484.62%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
312.61%
10Y revenue/share CAGR above 1.5x CX's 142.84%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
128.85%
5Y revenue/share CAGR above 1.5x CX's 63.60%. David Dodd would look for consistent product or market expansions fueling outperformance.
82.23%
3Y revenue/share CAGR at 50-75% of CX's 112.80%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
314.20%
Net income/share CAGR above 1.5x CX's 16.70% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
280.00%
5Y net income/share CAGR above 1.5x CX's 20.31%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
258.19%
3Y net income/share CAGR 50-75% of CX's 436.57%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
We expand SG&A while CX cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.